157 related articles for article (PubMed ID: 16545899)
41. Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques.
Uno Y; Takahira R; Murayama N; Ishii Y; Ikenaka Y; Ishizuka M; Yamazaki H; Ikushiro S
Biochem Pharmacol; 2018 Sep; 155():172-181. PubMed ID: 29944869
[TBL] [Abstract][Full Text] [Related]
42. Dietary modulation of phase 1 and phase 2 activities with benzo(a)pyrene and related compounds in the intestine but not the liver of the channel catfish, Ictalurus punctatus.
James MO; Altman AH; Morris K; Kleinow KM; Tong Z
Drug Metab Dispos; 1997 Mar; 25(3):346-54. PubMed ID: 9172953
[TBL] [Abstract][Full Text] [Related]
43. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
[TBL] [Abstract][Full Text] [Related]
44. Biphasic kinetics of quaternary ammonium glucuronide formation from amitriptyline and diphenhydramine in human liver microsomes.
Breyer-Pfaff U; Fischer D; Winne D
Drug Metab Dispos; 1997 Mar; 25(3):340-5. PubMed ID: 9172952
[TBL] [Abstract][Full Text] [Related]
45. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
46. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
47. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
Yoder Graber AL; RamÃrez J; Innocenti F; Ratain MJ
Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
[TBL] [Abstract][Full Text] [Related]
48. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
Katoh M; Matsui T; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
[TBL] [Abstract][Full Text] [Related]
49. Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7.
Sabolovic N; Magdalou J; Netter P; Abid A
Life Sci; 2000; 67(2):185-96. PubMed ID: 10901286
[TBL] [Abstract][Full Text] [Related]
50. Relationship between CYP1A induction by indole-3-carbinol or flutamide and liver tumor-promoting potential in rats.
Shimamoto K; Dewa Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Sep; 85(9):1159-66. PubMed ID: 21203749
[TBL] [Abstract][Full Text] [Related]
51. Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources.
Iwuchukwu OF; Nagar S
Xenobiotica; 2010 Feb; 40(2):102-8. PubMed ID: 20017604
[TBL] [Abstract][Full Text] [Related]
52. Decrease in serum thyroxine level by phenobarbital in rats is not necessarily dependent on increase in hepatic UDP-glucuronosyltransferase.
Kato Y; Suzuki H; Ikushiro S; Yamada S; Degawa M
Drug Metab Dispos; 2005 Nov; 33(11):1608-12. PubMed ID: 16049124
[TBL] [Abstract][Full Text] [Related]
53. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
54. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
[TBL] [Abstract][Full Text] [Related]
55. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
[TBL] [Abstract][Full Text] [Related]
56. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
57. UDP-glucuronosyltransferase activity in human liver and colon.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Gastroenterology; 1999 Jan; 116(1):149-60. PubMed ID: 9869613
[TBL] [Abstract][Full Text] [Related]
58. Activity and expression of various isoforms of uridine diphosphate glucuronosyltransferase are differentially regulated during hepatic regeneration in rats.
Tian H; Ou J; Strom SC; Venkataramanan R
Pharm Res; 2005 Dec; 22(12):2007-15. PubMed ID: 16222444
[TBL] [Abstract][Full Text] [Related]
59. Expression and inducibility of UDP-glucuronosyltransferases 1-naphthol in human cultured hepatocytes and hepatocarcinoma cell lines.
Abid A; Sabolovic N; Magdalou J
Life Sci; 1997; 60(22):1943-51. PubMed ID: 9180348
[TBL] [Abstract][Full Text] [Related]
60. Dysregulations of UDP-glucuronosyltransferases in rats with valproic acid and high fat diet induced fatty liver.
Zhang L; Chu X; Wang H; Xie H; Guo C; Cao L; Zhou X; Wang G; Hao H
Eur J Pharmacol; 2013 Dec; 721(1-3):277-85. PubMed ID: 24056123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
